France-Based Property Group Unibail-Rodamco 'A' Long-Term and 'A-1' Short-Term Ratings Affirmed; Outlook Stable Jun 10

  • ID: 1886219
  • June 2010
  • Standard & Poors
1 of 3

France-based property group Unibail-Rodamco has, in our view, a large, high-quality, and diversified retail property portfolio that provides stable cash flows. It also has a solid capital structure. We are affirming our 'A' long-term and 'A-1' short-term corporate credit ratings on Unibail-Rodamco. The stable outlook mainly reflects our view of the group's ability to maintain adequate leverage and financial flexibility amid difficult market conditions. LONDON (Standard & Poor's) June 4, 2010--Standard & Poor's Ratings Services said today that it affirmed its 'A' long-term and 'A-1' short-term corporate credit ratings on France-based property group Unibail-Rodamco. The outlook is stable. "The ratings on France-based property group Unibail-Rodamco reflect our view of its position as Europe's largest real estate company; its high-quality and...

Companies mentioned in this report are:
- Unibail-Rodamco

Action: Affirmed
Action: Outlook: Stable

Standard and Poors RatingsXpress Credit Research provides in-depth coverage of international corporates, financial institutions, insurance companies, utilities, sovereigns and structured finance programs. RatingsXpress Credit Research lets users determine the credit rating of holdings and identify key factors underlying an issuer's creditworthiness, distinguishes the different risk exposures for new and existing deals, and provides an understanding of how their analysts interpret key regulatory, political and environmental events and their economic impact.

Research type: News
This product is a is a brief one-page announcement of no more than 500 words with a quote from the analyst. It is media and investor focused with no accompanying commentary article.

Note: Product cover images may vary from those shown
2 of 3

- Unibail-Rodamco

Note: Product cover images may vary from those shown
3 of 3
Note: Product cover images may vary from those shown




Our Clients

  • Fluidigm Corporation
  • Apple, Inc.
  • CEVA Santé Animale
  • Abbott Laboratories Ltd.
  • Merck Group
  • Allergan Inc.
  • Pfizer Inc.